Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share ...

Here are some of the major companies whose stocks moved on the week’s news.

Goldman Sachs analyst James Quigley maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK875.00.

TD Cowen analyst Michael Nedelcovych maintained a Buy rating on Novo Nordisk (NVO – Research Report) today. The company’s shares closed ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Health care, ride sharing, and the emerging world of YouTube entertainers are among industries leading investors have picked ...